Sina Adibi and experts from Optum life sciences learn how the Optum® Digital Research Network is disrupting clinical trials. Clinical trials are facing new challenges to streamline, decentralize and modernize. Changing regulatory direction is ushering in:

• The need for new protocols
• Pressure on sponsors and contract research organizations (CROs) to recruit patients more efficiently for their trials
• Challenges for research sites to find new ways to locate qualified patients for potential trials

Optum is leveraging innovative approaches to address the clinical trial continuum. This includes new analytic tools that modernize how sponsors and sites work together, and streamline the recruitment process by identifying sites for sponsors while helping sites more quickly and easily identify potential patients. In a frictionless data world, the Optum Digital Research Network focuses on the data coming out of EMRs and EHRs and combines it with other available sources to address these problems. This series will cover key topics including:

• Who is Optum? How is the Optum Digital Research Network poised to evolvethe clinical trial process? • How will leveraging frictionless data make it easier on sites?
• How can one enhance data quality, eliminate data duplication and source data verification?
• With the ever-increasing complexity of clinical trials, why is patient selection so critical?
• How does one take patient recruitment into account at the time of protocol design?
• What are best practices for sponsors and CROs in adopting new digital tools like EMR/EHR